| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |